Analysis 
psychosis
These analyses were based on the study drug actually chosen by the patient and the physician, resulting in the following groups: amisulpride (n = 52), aripiprazole (n = 51) and olanzapine (n = 41). The only significant finding was an indirect association in the initial phase (b = -0.34, p < 0.001; long-term phase: b = -0.01, p = 0.093; relation between change in insight and change in mPANSS: b = -0.001, p < 0.001), meaning improved insight was associated with reduced total psychosis symptoms. In this model, we found no significant differences among the three study drugs on insight (initial phase: α